Japan Lung Cancer Therapeutic Market (2025-2031) | Segments, Demand, Investment Trends, Challenges, Strategy, Outlook, Consumer Insights, Forecast, Pricing Analysis, Analysis, Competitive, Restraints, Size, Share, Strategic Insights, Opportunities, Value, Revenue, Drivers, Segmentation, Trends, Industry, Competition, Growth, Companies, Supply

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Lung Cancer Therapeutic Market Revenues & Volume, 2021 & 2031F

3.3 Japan Lung Cancer Therapeutic Market - Industry Life Cycle

3.4 Japan Lung Cancer Therapeutic Market - Porter's Five Forces

3.5 Japan Lung Cancer Therapeutic Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 Japan Lung Cancer Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 Japan Lung Cancer Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of lung cancer in Japan

4.2.2 Advancements in lung cancer therapeutic drugs and treatments

4.2.3 Growing adoption of targeted therapies in lung cancer treatment

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval in Japan

4.3.2 High cost associated with lung cancer therapies

4.3.3 Limited accessibility to advanced lung cancer treatments in certain regions of Japan

6.1 Japan Lung Cancer Therapeutic Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Therapy Type, 2021 - 2031F

6.1.3 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F

6.1.4 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F

6.1.5 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.1.6 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F

6.1.7 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Surgery, 2021 - 2031F

6.2 Japan Lung Cancer Therapeutic Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Kinase Inhibitors, 2021 - 2031F

6.2.3 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Platinum-based Drugs, 2021 - 2031F

6.2.4 Japan Lung Cancer Therapeutic Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021 - 2031F

6.2.5 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.3 Japan Lung Cancer Therapeutic Market, By End User

6.3.1 Overview and Analysis

6.3.2 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.3.3 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F

6.3.4 Japan Lung Cancer Therapeutic Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F

7.1 Japan Lung Cancer Therapeutic Market Export to Major Countries

7.2 Japan Lung Cancer Therapeutic Market Imports from Major Countries

8.1 Percentage increase in early-stage lung cancer diagnoses

8.2 Adoption rate of targeted therapies in lung cancer treatment

8.3 Patient survival rates post lung cancer treatment

9.1 Japan Lung Cancer Therapeutic Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 Japan Lung Cancer Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 Japan Lung Cancer Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Japan Lung Cancer Therapeutic Market Revenue Share, By Companies, 2024

10.2 Japan Lung Cancer Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters